[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Liver Failure Therapeutics Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

December 2020 | 109 pages | ID: L43201FE6D06EN
99Strategy

US$ 3,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Further key aspects of the report indicate that:

Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Liver Failure Therapeutics market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Liver Failure Therapeutics market segmented into
  • Ornithine Phenylacetate
  • MTL-CEBPA
  • F-573
  • BL-1220
  • PP-100
  • Others
Based on the end-use, the global Liver Failure Therapeutics market classified into
  • Clinic
  • Hospital
  • Others
Based on geography, the global Liver Failure Therapeutics market segmented into
  • North America [U.S., Canada, Mexico]
  • Europe [Germany, UK, France, Italy, Rest of Europe]
  • Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
  • South America [Brazil, Argentina, Rest of Latin America]
  • Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
  • Alfact Innovation
  • BioLineRx Ltd
  • Cell2B Advanced Therapeutics SA
  • Conatus Pharmaceuticals Inc
  • Immune Pharmaceuticals Inc
  • Mina Therapeutics Ltd
  • Mylan NV
  • Ocera Therapeutics Inc
  • PledPharma AB
  • Promethera Biosciences SA
  • Silence Therapeutics Plc
  • Unicyte AG
  • Ventria Bioscience
  • Vital Therapies Inc
1 RESEARCH SCOPE

1.1 Research Product Definition
1.2 Research Segmentation
  1.2.1 Product Type
  1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology

2 GLOBAL LIVER FAILURE THERAPEUTICS INDUSTRY

2.1 Summary about Liver Failure Therapeutics Industry
2.2 Liver Failure Therapeutics Market Trends
  2.2.1 Liver Failure Therapeutics Production & Consumption Trends
  2.2.2 Liver Failure Therapeutics Demand Structure Trends
2.3 Liver Failure Therapeutics Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
  3.2.1 Drivers
  3.2.2 Restraints
  3.2.3 Opportunity
  3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)
  4.1.1 North America (U.S., Canada and Mexico)
  4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
  4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
  4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
  4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
  4.2.1 Ornithine Phenylacetate
  4.2.2 MTL-CEBPA
  4.2.3 F-573
  4.2.4 BL-1220
  4.2.5 PP-100
  4.2.6 Others
4.3 Consumption Segmentation (2017 to 2021f)
  4.3.1 Clinic
  4.3.2 Hospital
  4.3.3 Others

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)
  5.1.1 U.S.
  5.1.2 Canada
  5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
  5.2.1 Ornithine Phenylacetate
  5.2.2 MTL-CEBPA
  5.2.3 F-573
  5.2.4 BL-1220
  5.2.5 PP-100
  5.2.6 Others
5.3 Consumption Segmentation (2017 to 2021f)
  5.3.1 Clinic
  5.3.2 Hospital
  5.3.3 Others
5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)
  6.1.1 Germany
  6.1.2 UK
  6.1.3 France
  6.1.4 Italy
  6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
  6.2.1 Ornithine Phenylacetate
  6.2.2 MTL-CEBPA
  6.2.3 F-573
  6.2.4 BL-1220
  6.2.5 PP-100
  6.2.6 Others
6.3 Consumption Segmentation (2017 to 2021f)
  6.3.1 Clinic
  6.3.2 Hospital
  6.3.3 Others
6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)
  7.1.1 China
  7.1.2 India
  7.1.3 Japan
  7.1.4 South Korea
  7.1.5 Southeast Asia
  7.1.6 Australia
  7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
  7.2.1 Ornithine Phenylacetate
  7.2.2 MTL-CEBPA
  7.2.3 F-573
  7.2.4 BL-1220
  7.2.5 PP-100
  7.2.6 Others
7.3 Consumption Segmentation (2017 to 2021f)
  7.3.1 Clinic
  7.3.2 Hospital
  7.3.3 Others
7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)
  8.1.1 Brazil
  8.1.2 Argentina
  8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
  8.2.1 Ornithine Phenylacetate
  8.2.2 MTL-CEBPA
  8.2.3 F-573
  8.2.4 BL-1220
  8.2.5 PP-100
  8.2.6 Others
8.3 Consumption Segmentation (2017 to 2021f)
  8.3.1 Clinic
  8.3.2 Hospital
  8.3.3 Others
8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)
  9.1.1 GCC
  9.1.2 North Africa
  9.1.3 South Africa
  9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
  9.2.1 Ornithine Phenylacetate
  9.2.2 MTL-CEBPA
  9.2.3 F-573
  9.2.4 BL-1220
  9.2.5 PP-100
  9.2.6 Others
9.3 Consumption Segmentation (2017 to 2021f)
  9.3.1 Clinic
  9.3.2 Hospital
  9.3.3 Others
9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players
  10.1.1 Alfact Innovation
  10.1.2 BioLineRx Ltd
  10.1.3 Cell2B Advanced Therapeutics SA
  10.1.4 Conatus Pharmaceuticals Inc
  10.1.5 Immune Pharmaceuticals Inc
  10.1.6 Mina Therapeutics Ltd
  10.1.7 Mylan NV
  10.1.8 Ocera Therapeutics Inc
  10.1.9 PledPharma AB
  10.1.10 Promethera Biosciences SA
  10.1.11 Silence Therapeutics Plc
  10.1.12 Unicyte AG
  10.1.13 Ventria Bioscience
  10.1.14 Vital Therapies Inc
10.2 Liver Failure Therapeutics Sales Date of Major Players (2017-2020e)
  10.2.1 Alfact Innovation
  10.2.2 BioLineRx Ltd
  10.2.3 Cell2B Advanced Therapeutics SA
  10.2.4 Conatus Pharmaceuticals Inc
  10.2.5 Immune Pharmaceuticals Inc
  10.2.6 Mina Therapeutics Ltd
  10.2.7 Mylan NV
  10.2.8 Ocera Therapeutics Inc
  10.2.9 PledPharma AB
  10.2.10 Promethera Biosciences SA
  10.2.11 Silence Therapeutics Plc
  10.2.12 Unicyte AG
  10.2.13 Ventria Bioscience
  10.2.14 Vital Therapies Inc
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
  11.3.1 Impact of COVID-19
  11.3.2 Geopolitics Overview
  11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT
LIST OF TABLES
Table Liver Failure Therapeutics Product Type Overview
Table Liver Failure Therapeutics Product Type Market Share List
Table Liver Failure Therapeutics Product Type of Major Players
Table Brief Introduction of Alfact Innovation
Table Brief Introduction of BioLineRx Ltd
Table Brief Introduction of Cell2B Advanced Therapeutics SA
Table Brief Introduction of Conatus Pharmaceuticals Inc
Table Brief Introduction of Immune Pharmaceuticals Inc
Table Brief Introduction of Mina Therapeutics Ltd
Table Brief Introduction of Mylan NV
Table Brief Introduction of Ocera Therapeutics Inc
Table Brief Introduction of PledPharma AB
Table Brief Introduction of Promethera Biosciences SA
Table Brief Introduction of Silence Therapeutics Plc
Table Brief Introduction of Unicyte AG
Table Brief Introduction of Ventria Bioscience
Table Brief Introduction of Vital Therapies Inc
Table Products & Services of Alfact Innovation
Table Products & Services of BioLineRx Ltd
Table Products & Services of Cell2B Advanced Therapeutics SA
Table Products & Services of Conatus Pharmaceuticals Inc
Table Products & Services of Immune Pharmaceuticals Inc
Table Products & Services of Mina Therapeutics Ltd
Table Products & Services of Mylan NV
Table Products & Services of Ocera Therapeutics Inc
Table Products & Services of PledPharma AB
Table Products & Services of Promethera Biosciences SA
Table Products & Services of Silence Therapeutics Plc
Table Products & Services of Unicyte AG
Table Products & Services of Ventria Bioscience
Table Products & Services of Vital Therapies Inc
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Liver Failure Therapeutics Market Forecast (Million USD) by Region 2021f-2026f
Table Global Liver Failure Therapeutics Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Liver Failure Therapeutics Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Liver Failure Therapeutics Market Forecast (Million USD) Share by Demand 2021f-2026f
LIST OF FIGURES
Figure Global Liver Failure Therapeutics Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Liver Failure Therapeutics Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Liver Failure Therapeutics Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Liver Failure Therapeutics Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Liver Failure Therapeutics Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Liver Failure Therapeutics Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Liver Failure Therapeutics Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ornithine Phenylacetate Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure MTL-CEBPA Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure F-573 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure BL-1220 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PP-100 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ornithine Phenylacetate Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure MTL-CEBPA Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure F-573 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure BL-1220 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PP-100 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ornithine Phenylacetate Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure MTL-CEBPA Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure F-573 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure BL-1220 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PP-100 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ornithine Phenylacetate Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure MTL-CEBPA Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure F-573 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure BL-1220 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PP-100 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ornithine Phenylacetate Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure MTL-CEBPA Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure F-573 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure BL-1220 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PP-100 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ornithine Phenylacetate Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure MTL-CEBPA Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure F-573 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure BL-1220 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PP-100 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Liver Failure Therapeutics Sales Revenue (Million USD) of Alfact Innovation 2017-2020e
Figure Liver Failure Therapeutics Sales Revenue (Million USD) of BioLineRx Ltd 2017-2020e
Figure Liver Failure Therapeutics Sales Revenue (Million USD) of Cell2B Advanced Therapeutics SA 2017-2020e
Figure Liver Failure Therapeutics Sales Revenue (Million USD) of Conatus Pharmaceuticals Inc 2017-2020e
Figure Liver Failure Therapeutics Sales Revenue (Million USD) of Immune Pharmaceuticals Inc 2017-2020e
Figure Liver Failure Therapeutics Sales Revenue (Million USD) of Mina Therapeutics Ltd 2017-2020e
Figure Liver Failure Therapeutics Sales Revenue (Million USD) of Mylan NV 2017-2020e
Figure Liver Failure Therapeutics Sales Revenue (Million USD) of Ocera Therapeutics Inc 2017-2020e
Figure Liver Failure Therapeutics Sales Revenue (Million USD) of PledPharma AB 2017-2020e
Figure Liver Failure Therapeutics Sales Revenue (Million USD) of Promethera Biosciences SA 2017-2020e
Figure Liver Failure Therapeutics Sales Revenue (Million USD) of Silence Therapeutics Plc 2017-2020e
Figure Liver Failure Therapeutics Sales Revenue (Million USD) of Unicyte AG 2017-2020e
Figure Liver Failure Therapeutics Sales Revenue (Million USD) of Ventria Bioscience 2017-2020e
Figure Liver Failure Therapeutics Sales Revenue (Million USD) of Vital Therapies Inc 2017-2020e


More Publications